Further, this TIMP-1-CD63 (LAMP3) signaling axis has been identified as playing a role in tumor metabolism of breast cancer cells by downstream upregulating aerobic glycolysis through carbonic anhydrase IX (CAIX) and thereby extending cell survival [26]. Here, CA9 is linked to breast cancer.